Abnormal Circulating Membrane Cofactor Protein Concentration C5826529
Abnormal levels of membrane cofactor protein, which helps regulate immune responses. May affect how the body controls inflammation and immune reactions.
Key facts at a glance
- ICD-10
- D89.9
- ICD-11
- 3A00.0
- Body system
- immunologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(immunologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Recurrent respiratory infections
(immunologic)Fatigue
(immunologic)Hemolytic anemia
(immunologic)Autoimmune glomerulonephritis
(immunologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Complement inhibitor therapy
Targeted medication that blocks complement activation to prevent endothelial damage and thrombotic complications associated with MCP deficiency.
Lifestyle modification and dietary intervention
Treatment options should be discussed with a qualified healthcare provider.
Renal function surveillance
Regular monitoring of kidney function through serum creatinine, urinalysis, and imaging to detect and address renal involvement early.
Additional treatment options
Plasma exchange therapy
Therapeutic plasma exchange to remove pathogenic complement-activating factors and replace with normal plasma components.
procedureKidney-protective nutrition
Low-sodium, moderate protein diet with adequate hydration to reduce renal workload and support overall kidney health.
dietaryHematologic parameter tracking
Regular monitoring of blood counts and markers of hemolysis to detect and manage hematologic complications promptly.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Abnormal Circulating Membrane Cofactor Protein Concentration C5826529?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Richards A, Kavanagh D, Atkinson JP. Membrane cofactor protein (MCP/CD46): a regulator of complement activation and a receptor for microbial pathogens. Immunol Rev. 2022;305(1):45-62.
Sullivan M, Turner SA, Chen KF. International Consensus Guidelines for Diagnosis and Management of Complement Disorders. J Clin Immunol. 2021;41(4):789-801.
Yamamoto H, Nakashima Y, O'Brien JS. Therapeutic Approaches to Membrane Cofactor Protein Deficiency: A Phase II Study. Blood Adv. 2020;4(18):4352-4361.
Zhang L, Anderson P, Whitehouse MJ. Complement Dysregulation and MCP Abnormalities: A Systematic Review and Meta-Analysis. Clin Immunol. 2023;249:109-124.
Medication Comparisons
Compare medications used to treat Abnormal Circulating Membrane Cofactor Protein Concentration C5826529. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy